Ice cream developed by the University of Auckland and Fonterra may be successful in reducing the side effects of chemotherapy.
The ice cream, known as ReCharge, has started Phase 2 clinical trials in New Zealand to assess its effectiveness against Chemotherapy Induced Diarrhoea (CID) and anaemia, but the ‘dessert with a difference’ could also reduce weight loss and damage to the immune system during chemotherapy.
Oncology Centres at Whangarei, Auckland, Waikato, Palmerston North, Wellington, Christchurch, Dunedin and Invercargill are taking part in the trial. Around 10 patients are already signed up for a daily regime that includes eating a 100 gram tub of strawberry ice cream containing two active dairy ingredients that combine to address the unpleasant side effects of chemotherapy. Cancer Trials New Zealand (CTNZ) is currently seeking 190 additional volunteers for the trial.
If trials are successful it will be great news for cancer patients.
It could also bring benefits for farmers.
There is huge potential in the development of “farmaceuticals” . These medicines using farm produce could provide opportunities for diversification and added value for producers.